Weighing up the pros and cons of immune checkpoint inhibitors in the treatment of melanoma.

View/Open

Accepted version (344.4Kb)

Publication Date

2016-06

ICR Author

Author

Spain, L

Larkin, J

Type

Journal Article

Metadata

Show full item record

URL

https://repository.icr.ac.uk/handle/internal/574

Collections

Clinical Studies

Licenseref URL

http://www.rioxx.net/licenses/all-rights-reserved

Version of record

10.2217/imt.16.6

Research team

Melanoma and Kidney Cancer

Language

eng

License start date

2016-06

Citation

Immunotherapy, 2016, 8 (6), pp. 677 - 679